Effect of Buyang Huanwu Decoction and its active fractions on caspase expression after cerebral ischemia-reperfusion in rats

Chinese Traditional and Herbal Drugs

Volumn 37, Issue 7, 2006, Pages 1041-1045

  Zhang, Shu Ping ^a   Liang, Yan ^a   Deng, Chang Qing ^a  

^a HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Buyang Huanwu Decoction (BHD); Cerebral ischemia reperfusion; Cysteine aspirate protease (caspase); Reverse transcription polymerase chain reaction (RT PCR)

Indexed keywords

ALKALOID DERIVATIVE; BUYANG HUANWU; CASPASE 3; CASPASE 8; CHINESE DRUG; GLYCOSIDE; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; PANAX NOTOGINSENG EXTRACT; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY LIGATION; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33748684423     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Schulz J B, Weller M, Matthews R T, et al. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia [J]. Cell Death Differ, 1998, 5(10): 845-847.
2. Liao C L, Tong L, Chen Y Y. Effect of Buyang Huanwu Tang on the expression of caspase-3 mRNA in the ischemic penumbra of rats with cerebral ischemia [J]. Chin J Clin Rehab, 2004, 8(19): 3821-3823.
3. Deng C Q, Wang M, Tang Y H, et al. Effects of Buyang Huanwu Decoction and its available composition combination on neuronal injury hippocampal CA1 area after cerebral ischemic reperfusion in gerbils [J]. China J Basic Med Tradit Chin Med, 2001, 7(11): 38-41.
4. Tang Y H, Deng C Q, Liu W H, et al. Effect of four kinds of active fractions of Buyang Huanwu Decoction on cerebral infarction volume in focal cerebral ischemia rats [J]. Chin Tradit Herb Drugs, 2005, 36(2): 236-239.
5. Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniotomy in rats [J]. Stroke, 1989, 20: 84-86.
6. Zhang X M. The focuses in the researches of apoptosis [J]. Chin J Pharmacol Toxicol, 2000, 14(2): 81-85.
7. Song Y, Wei E Q, Chen Z. Caspase and central nervous system disease [J]. Chin J Cell Biol, 2004, 24(3): 227-230.
8. Nunez G, Benedict M A, Hu Y, et al. Caspase: the proteases of the apoptotic pathway [J]. Oncogene, 1998, 17: 3237-3245.
9. Hayashi Y, Jikihara I, Yagi T, et al. Immunohistochemical investigation of caspase-1 and effect of caspaae-1 inhibitor in delayed neuronal death after transient cerebral ischemia [J]. Brain Res, 2001, 2(1-2): 113-120.
10. Srinivasula S M, Fernandes-Alnemri T, Zangrilli J, et al. The ced-3/ interleukin 1 beta converting enzyme-like homolog Mch 6 and the lamincleaving enzyme Mch 2 alpha are substrates for the apoptotic mediator cpp32 [J]. J Biol Chem, 1996, 271(43): 27009-27106.
11. Reed J C. Apoptosis-based therapies [J]. Nat Rev Drug Discov, 2002, 1(2): 111-121.
12. Matushita K, Wu Y Q, Qiu J H, et al. Fas receptor and neuronal cell death after spinal cord ischemia [J]. J Neurosci, 2000, 20(18): 6879-6887.
13. He W, Zhu Z P. Effect of Panax notoginseng saponins on the content of IL-8 in serum after cerebral ischemia-reperfusion in rat [J]. J Radioimmunol, 2002, 15 (5): 267-268.